Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Details

Connection

Laura Dunn to Clinical Trials as Topic

This is a "connection" page, showing publications Laura Dunn has written about Clinical Trials as Topic.

 
Connection Strength
  
 
 
2.132
  
  1. Dunn LB, Wiley J, Garrett S, Hlubocky F, Daugherty C, Trupin L, Munster P, Dohan D. Interest in initiating an early phase clinical trial: results of a longitudinal study of advanced cancer patients. Psychooncology. 2017 Oct; 26(10):1604-1610.
    View in: PubMed
    Score: 0.456
  2. Hickman NJ, Prochaska JJ, Dunn LB. Screening for understanding of research in the inpatient psychiatry setting. J Empir Res Hum Res Ethics. 2011 Sep; 6(3):65-72.
    View in: PubMed
    Score: 0.327
  3. Dunn LB, Gordon NE. Improving informed consent and enhancing recruitment for research by understanding economic behavior. JAMA. 2005 Feb 02; 293(5):609-12.
    View in: PubMed
    Score: 0.207
  4. Dunn LB, Jeste DV. Enhancing informed consent for research and treatment. Neuropsychopharmacology. 2001 Jun; 24(6):595-607.
    View in: PubMed
    Score: 0.161
  5. Leykin Y, Dunn LB, Mu?oz RF. The effect of depression on the decision to join a clinical trial. J Consult Clin Psychol. 2017 Jul; 85(7):751-756.
    View in: PubMed
    Score: 0.121
  6. Iltis AS, Misra S, Dunn LB, Brown GK, Campbell A, Earll SA, Glowinski A, Hadley WB, Pies R, Dubois JM. Addressing risks to advance mental health research. JAMA Psychiatry. 2013 Dec; 70(12):1363-71.
    View in: PubMed
    Score: 0.095
  7. Dunn LB, Fisher SR, Hantke M, Appelbaum PS, Dohan D, Young JP, Roberts LW. "Thinking about it for somebody else": Alzheimer's disease research and proxy decision makers' translation of ethical principles into practice. Am J Geriatr Psychiatry. 2013 Apr; 21(4):337-45.
    View in: PubMed
    Score: 0.090
  8. Overton E, Appelbaum PS, Fisher SR, Dohan D, Roberts LW, Dunn LB. Alternative decision-makers' perspectives on assent and dissent for dementia research. Am J Geriatr Psychiatry. 2013 Apr; 21(4):346-54.
    View in: PubMed
    Score: 0.090
  9. Christopher PP, Leykin Y, Appelbaum PS, Holtzheimer PE, Mayberg HS, Dunn LB. Enrolling in deep brain stimulation research for depression: influences on potential subjects' decision making. Depress Anxiety. 2012 Feb; 29(2):139-46.
    View in: PubMed
    Score: 0.083
  10. Rabins P, Appleby BS, Brandt J, DeLong MR, Dunn LB, Gabri?ls L, Greenberg BD, Haber SN, Holtzheimer PE, Mari Z, Mayberg HS, McCann E, Mink SP, Rasmussen S, Schlaepfer TE, Vawter DE, Vitek JL, Walkup J, Mathews DJ. Scientific and ethical issues related to deep brain stimulation for disorders of mood, behavior, and thought. Arch Gen Psychiatry. 2009 Sep; 66(9):931-7.
    View in: PubMed
    Score: 0.071
  11. Dunn LB, Kim DS, Fellows IE, Palmer BW. Worth the risk? Relationship of incentives to risk and benefit perceptions and willingness to participate in schizophrenia research. Schizophr Bull. 2009 Jul; 35(4):730-7.
    View in: PubMed
    Score: 0.064
  12. Jeste DV, Palmer BW, Golshan S, Eyler LT, Dunn LB, Meeks T, Glorioso D, Fellows I, Kraemer H, Appelbaum PS. Multimedia consent for research in people with schizophrenia and normal subjects: a randomized controlled trial. Schizophr Bull. 2009 Jul; 35(4):719-29.
    View in: PubMed
    Score: 0.064
  13. Mittal D, Palmer BW, Dunn LB, Landes R, Ghormley C, Beck C, Golshan S, Blevins D, Jeste DV. Comparison of two enhanced consent procedures for patients with mild Alzheimer disease or mild cognitive impairment. Am J Geriatr Psychiatry. 2007 Feb; 15(2):163-7.
    View in: PubMed
    Score: 0.059
  14. Dunn LB, Palmer BW, Appelbaum PS, Saks ER, Aarons GA, Jeste DV. Prevalence and correlates of adequate performance on a measure of abilities related to decisional capacity: differences among three standards for the MacCAT-CR in patients with schizophrenia. Schizophr Res. 2007 Jan; 89(1-3):110-8.
    View in: PubMed
    Score: 0.058
  15. Dunn LB, Palmer BW, Keehan M. Understanding of placebo controls among older people with schizophrenia. Schizophr Bull. 2006 Jan; 32(1):137-46.
    View in: PubMed
    Score: 0.054
  16. Dunn LB, Jeste DV. Problem areas in the understanding of informed consent for research: study of middle-aged and older patients with psychotic disorders. Psychopharmacology (Berl). 2003 Dec; 171(1):81-5.
    View in: PubMed
    Score: 0.046
  17. Young BE, Goodmann DR, Hamlin E, Tabaczyk O, Dunn LB, Mu?oz RF, Leykin Y. Is it worth it? Greater risk aversion with lower life satisfaction among depressed individuals. Psychol Health Med. 2024 Apr; 29(4):732-742.
    View in: PubMed
    Score: 0.046
  18. Bell E, Racine E, Chiasson P, Dufourcq-Brana M, Dunn LB, Fins JJ, Ford PJ, Glannon W, Lipsman N, Macdonald ME, Mathews DJ, McAndrews MP. Beyond consent in research. Revisiting vulnerability in deep brain stimulation for psychiatric disorders. Camb Q Healthc Ethics. 2014 Jul; 23(3):361-8.
    View in: PubMed
    Score: 0.025
  19. Palmer BW, Dunn LB, Depp CA, Eyler LT, Jeste DV. Decisional capacity to consent to research among patients with bipolar disorder: comparison with schizophrenia patients and healthy subjects. J Clin Psychiatry. 2007 May; 68(5):689-96.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.